Showing 5 most recent research articles. For a complete list of publications, please click here:

  1. Gusev, E, Liang, F, Bhattarai, S, Broering, FE, Leduc-Gaudet, JP, Hussain, SN, Radzioch, D, Petrof, BJ (2022). Characterization of skeletal muscle wasting pathways in diaphragm and limb muscles of cystic fibrosis mice. Am J Physiol Regul Integr Comp Physiol322,R551-R561.
  2. Bhattarai, S, Li, Q, Ding, J, Liang, F, Gusev, E, Lapohos, O, Fonseca, GJ, Kaufmann, E, Divangahi, M, Petrof, BJ et al. (2022). TLR4 is a regulator of trained immunity in a murine model of Duchenne muscular dystrophy. Nat Commun13,879.
  3. Petrof, BJ (2021). Macrophage plasticity in Duchenne muscular dystrophy: a nexus of pathological remodelling with therapeutic implications. J Physiol,.
  4. Kaminska, M, Zielinski, D, Petrof, BJ, Westenberg, JN, Constantin, E (2021). Diagnosing sleep-disordered breathing in neuromuscular diseases in 2021. J Clin Sleep Med17,2567-2568.
  5. Crulli, B, Kawaguchi, A, Praud, JP, Petrof, BJ, Harrington, K, Emeriaud, G (2021). Evolution of inspiratory muscle function in children during mechanical ventilation. Crit Care25,229.
Search PubMed

Podcast with Dr. Basil Petrof

February 2015
Accelerating new treatments for respiratory diseases
Innovation at the Glen: the CFI talks to our researchers

Basil Petrof heads the program for Translational Research in Respiratory Diseases at the Research Institute of the McGill University Health Centre. His research group recently participated in a clinical trial that proved the efficacy of a new therapy that burns away the muscle tissue in the lungs of asthmatic patients to help open their airways. It’s this kind of cutting-edge discovery that Petrof expects will move more rapidly from concept to proven treatment thanks to the new facilities at the RI-MUHC.

Podcast with Dr. Basil Petrof

October 2014
Patients Referred to Neurologists with Respiratory Symptoms: Is it Pompe Disease?

Listen here: